Friday May 13, 2022 

ACCREDITED SYMPOSIUM 

Changing the Face of Worsening Heart Failure 
Shelley Zieroth, MD (Chair); Justin Ezekowitz, MD; Lisa Mielniczuk, MD; Javed Butler, MBBS

PLENARY SESSION #1: RE-EXAMINING LV EJECTION IN HEART FAILURE 

Current and Promising Approaches to HfpEF 
Sanjiv Shah, MD

Super "PEF": Understanding EF over 60 
Kavita Sharma, MD 

A Phenotypic Approach to HFrEF Medicines 
Anique Ducharme, MD 

What to do When the Big 4 Aren't Enough 
Lisa Mielniczuk, MD

WORKSHOPS

CCS/CHFS Guidelines: New Standards of Care for HFrEF
Margot Davis, MD; Abhinav Sharma, MD

Lignes directrices de la SCC et de la SCIC pour le traitement de l’IC : les nouvelles normes de prise en charge de l’ICFEr
Nadia Giannetti, MD; Serge Lepage, MD

CHFS & HFSA Joint Workshop: 
Nursing Roles & Responsibilities - A Cross-Border Pulse Check
Rodolfo Pike, NP; Karen Harkness, RN, PhD (CHFS); Rebecca Reay, ACNP (HFSA)

POCUS for HF is BACK- with an AI Twist!
Ryan Davey, MD; Sabe De, MD

ACCREDITED SYMPOSIUM 

Innovations in Heart Failure Management in Canada 
Shelley Zieroth, MD (Co-Chair); Stephanie Poon, MD (Co-Chair); Jonathan Howlett, MD; David McFarlane, MBBS; Abhinav Sharma, MD, PhD

PLENARY SESSION #2: CHFS & JACC: HF JOINT PLENARY 
READING TIME

JACC HF: Great HF Papers of the Past Year
JoAnn Lindenfeld, MD (JACC: HF)

Diet and Heart Failure: Should we Challenge Current Practice?
Justin Ezekowitz, MBBCh

Heart-Kidney Interaction
Muthiah Vaduganathan, MD, MPH

Addressing the Gaps Left by Existing Guidelines
Eileen O'Meara, MD

WORKSHOPS 

Practical Proof for Digital HF Care
Abhinav Sharma, MD

Cardio-Oncology 2022
Paaladinesh Thavendiranathan, MD

Special Cardiomyopathies: Focus on Diagnosis
Nowell Fine, MD; Elizabeth Swiggum, MD; François Tournoux, MD

How to Treat VT Storm
Jacqueline Joza, MD

DAY 1 HIGHLIGHTS FROM OUR CO-CHAIRS 

Jonathan Howlett, MD; Serge Lepage, MD; Shelley Zieroth, MD 

Saturday May 14, 2022 

UNACCREDITED SYMPOSIUM

Good for the Heart, Good for the Kidneys: 
A Cased-Based Approach to Integrating SGLT2 Inhibitors
Jonathan Howlett, MD (Chair); Kim A. Connelly, MBBS; Louise Moist, MD

PLENARY SESSION #3: CHFS & HFA JOINT PLENARY
PREVENTING RECURRENT HOSPITALIZATIONS 

Worsening HF: What is it and Why is it Important?
Ovidiu Chioncel, MD

Diuretics and 'New' Drugs in AHF
Peter Liu, MD

Managing AF in Acute HF
Katia Dyrda, MD

Identifying the 'Sweet Spot' for Invasive Hemodynamic Monitoring
Finn Gustafsson, MD

SÉANCE PLÉNIÈRE #3:
PRÉVENIR LES HOSPITALISATIONS RÉCURRENTES

Détérioration clinique de l’insuffisance cardiaque : pathophysiologie et importance clinique
Mathieu Bernier, MD

Approche à l’insuffisance cardiaque aiguë : Diurétique et nouvelles avenues de traitement
Normand Racine, MD

Prise en charge de la FA en ADHF
Jean-François Roux, MD

Utilisation judicieuse du monitoring invasif
Catherine Bourque, MD

WORKSHOPS

Special Cardiomyopathies: Focus on Treatment
Margot Davis, MD; Michael McDonald, MD; Robert McKelvie, MD

Treatment of Refractory HF
Jennifer Amadio, MD; Stephanie Poon, MD

Managing Depression in Heart Failure
Heather Tulloch, MD; Karen Harkness, RN, PhD

Practically Starting and Stopping GDMT
Jacinthe Boulet, MD; Emmanuelle Ménard-Massie, MD

PLENARY SESSION #4: CHFS & HFSA JOINT PLENARY 
CUTTING EDGE HF THERAPIES

Has COVID-19 Taught us Anything about HF?
Anuradha Lala-Trinidade, MD

New Devices for HF
Akshay S. Desai, MD

Successes and Challenges with Percutaneous Valve Therapy
Anita Asgar, MD

Challenges with "Destination Therapy" in Canada
Nakul Sharma, MD

DAY 2 HIGHLIGHTS FROM OUR CO-CHAIRS 

Jonathan Howlett, MD; Serge Lepage, MD; Shelley Zieroth, MD